Amvuttra

heart monitor
Biotech

BridgeBio touts extension study data for ATTR-CM drug acoramidis

BridgeBio has presented more data for its TTR stabilizer acoramidis indicating it can become a force as a treatment for cardiomyopathy.
Kevin Dunleavy Nov 18, 2024 3:38pm
Heart drawn in the sand on the beach

BridgeBio touts case for acoramidis with post hoc study analysis

Sep 30, 2024 9:37am